Amicus Therapeutics, Inc.
FOLD
$9.94
$0.161.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 170.87% | -12.61% | -247.13% | 319.04% | 57.13% |
| Total Depreciation and Amortization | 1.19% | 0.82% | -10.00% | -5.94% | -0.55% |
| Total Amortization of Deferred Charges | 4.44% | 3.96% | 1.51% | 4.01% | 2.50% |
| Total Other Non-Cash Items | 5.08% | 16.55% | -6.48% | -10.19% | 1.78% |
| Change in Net Operating Assets | 65.97% | -583.39% | 113.74% | 0.54% | -496.48% |
| Cash from Operations | 234.43% | -441.92% | 298.11% | 82.95% | -201.23% |
| Capital Expenditure | 84.10% | -1,033.49% | 26.39% | 19.10% | 67.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.83% | 89.66% | -62.40% | -158.06% | 265.85% |
| Cash from Investing | 77.52% | 82.42% | -61.15% | -159.50% | 255.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -112.50% | 46.67% | 65.12% | -279.17% | 166.67% |
| Issuance of Common Stock | 747.50% | -61.90% | -94.66% | -90.61% | 2,328.51% |
| Repurchase of Common Stock | -279.86% | 96.34% | -1,323.91% | 70.34% | -65.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -229.75% | 96.58% | -1,166.55% | -93.97% | 2,222.52% |
| Foreign Exchange rate Adjustments | -112.02% | 107.24% | 55.10% | 161.79% | -1,610.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.17% | 28.97% | -59.09% | -182.18% | 5,697.94% |